Amgros 2026 1.478.a

Summary

The tender concerns framework agreements for medicines, specifically odevixibat hard capsules in strengths of 200, 400, 600 and 1200 micrograms. It is a non-exclusive procurement, and bidders may submit offers for one, several or all lots. No precise qualification requirements were provided; the exclusion grounds must be checked in the tender documents. For contract performance, the medicines must have a Danish marketing authorisation and be listed in Medicinpriser.dk, and the supplier must hold a medicines manufacturing, import or wholesale licence in the EU/EEA.